Only one clean $1M insider buy made the July 13-20 screen

The July 13-20 screen produced one clean qualifying purchase: Elevance Health President and CEO Gail Boudreaux bought 2,725 shares of ELV for $1,002,230 on July 17. The purchase came shortly after the insurer's second-quarter results and a post-earnings selloff. 12

The Form 4 detail breaks the purchase into two price bands, $366.41 and $368.25. OpenInsider classifies it as code P, a purchase of securities on an exchange or from another person, rather than an option exercise, tax transaction, or sale-after-exercise. 14

Boudreaux's prior qualifying purchase in the available ELV history was 8,500 shares at $286.94 on July 18, 2025, worth $2.44 million. ELV's latest completed-session close of $373.11 is 30.0% above that earlier transaction price. That is a favorable one-year mark-to-market comparison, but it is only one prior purchase, so it is not enough to establish a reliable hit rate. 15

The timing is the more useful context. Barron's reported that this was Boudreaux's first purchase of the year and that it followed the post-earnings decline. The stock's latest close sits only modestly above the weighted entry price, so the market has not yet provided much confirmation either way. 2

There is no qualifying cluster this week. After the financing, threshold, derivative, and date filters, ELV is the only officer/director signal that remains. A single purchase is a thin screen, even when the buyer is the CEO and the dollar value clears the threshold by a small margin.

The useful follow-up is whether Boudreaux buys again after the earnings reaction, not whether a one-off $1 million purchase proves the next move in ELV. The next screen should also check for additional Elevance insiders, which would turn a solitary CEO purchase into a cluster, and for a price response that persists beyond the first few sessions.